Celanese Corporation Reports 9% Net Sales Increase to $2.75 Billion in Q2 2026

Celanese Corporation reported its financial results for the second quarter of 2026, revealing a net sales increase of 9% to $2.75 billion, compared to $2.53 billion in the same period last year. For the first half of 2026, net sales reached $5.09 billion, up from $4.92 billion in the prior year. The company's gross profit for the quarter was $618 million, a rise from $534 million in Q2 2025, while operating profit increased to $276 million from $231 million year-over-year. However, net earnings attributable to Celanese Corporation decreased to $125 million, or $1.13 per diluted share, down from $197 million, or $1.80 per diluted share, in the previous year.

The company experienced significant changes in its operational landscape, including the completion of the sale of its Micromax® business for $493 million, which contributed a $50 million gain to the operating profit. This divestiture was part of a strategic move to streamline operations and focus on core business areas. Additionally, Celanese announced the planned closure of its facility in Lanaken, Belgium, which is expected to incur exit and shutdown costs of approximately $60 million through 2027.

Operationally, Celanese reported a decrease in volume in its Engineered Materials segment, primarily due to the aforementioned sale of the Micromax® business. The Acetyl Chain segment, however, saw a 19% increase in net sales, driven by higher pricing and favorable currency impacts. The company’s total assets as of June 30, 2026, were $21.41 billion, a slight decrease from $21.70 billion at the end of 2025. The company’s cash and cash equivalents increased to $1.36 billion, up from $1.26 billion at the end of the previous year.

Looking ahead, Celanese anticipates continued challenges in the market, particularly due to ongoing global macroeconomic weakness and supply chain dislocations. The company is focused on executing cost reduction initiatives and enhancing cash flow to support its deleveraging efforts. Management has indicated that they will continue to evaluate their capital allocation strategy, including potential adjustments to their dividend policy, which was significantly reduced in early 2025. The company remains committed to maintaining compliance with its financial covenants and expects to generate sufficient liquidity to meet its operational and capital investment needs in the foreseeable future.